Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review.

Expert review of respiratory medicine Pub Date : 2024-06-01 Epub Date: 2024-07-04 DOI:10.1080/17476348.2024.2375426
Rosaria Caprino, Giulia Sartori, Filippo Sartori, Alberto Fantin, Ernesto Crisafulli
{"title":"Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review.","authors":"Rosaria Caprino, Giulia Sartori, Filippo Sartori, Alberto Fantin, Ernesto Crisafulli","doi":"10.1080/17476348.2024.2375426","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The Exacerbation of Chronic Obstructive Pulmonary Disease (ECOPD), especially if leading to hospitalization, increases the risk of death. Our scoping review aims to identify updated mortality risk factors for both short- and long-term periods.</p><p><strong>Areas covered: </strong>A comprehensive search, covering the period from January 2013 to February 2024, was performed to identify eligible studies that consider factors associated with death in hospitalized ECOPD. We considered short-term mortality, up to one year (including in-hospital mortality, IHM) and long-term mortality over one year, without time limits. We excluded studies concerning the intensive care area.</p><p><strong>Expert opinion: </strong>We considered 38 studies, 32 and 8 reporting data about short- and long-term mortality, respectively. Two studies consider both periods. Several factors, some already known, others newly identified, have been evaluated and discussed. Some of these were related to the characteristics and severity of COPD (age, body mass index, lung impairment), and some considered the response to ECOPD. In this last context, we focused on the increasing role of biomarkers in predicting the mortality of patients, particularly IHM. Our factors associated with a worse prognosis may be helpful in clinical practice to identify patients at risk and, subsequently, determine a personalized approach.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"435-445"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17476348.2024.2375426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The Exacerbation of Chronic Obstructive Pulmonary Disease (ECOPD), especially if leading to hospitalization, increases the risk of death. Our scoping review aims to identify updated mortality risk factors for both short- and long-term periods.

Areas covered: A comprehensive search, covering the period from January 2013 to February 2024, was performed to identify eligible studies that consider factors associated with death in hospitalized ECOPD. We considered short-term mortality, up to one year (including in-hospital mortality, IHM) and long-term mortality over one year, without time limits. We excluded studies concerning the intensive care area.

Expert opinion: We considered 38 studies, 32 and 8 reporting data about short- and long-term mortality, respectively. Two studies consider both periods. Several factors, some already known, others newly identified, have been evaluated and discussed. Some of these were related to the characteristics and severity of COPD (age, body mass index, lung impairment), and some considered the response to ECOPD. In this last context, we focused on the increasing role of biomarkers in predicting the mortality of patients, particularly IHM. Our factors associated with a worse prognosis may be helpful in clinical practice to identify patients at risk and, subsequently, determine a personalized approach.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与慢性阻塞性肺病恶化住院患者死亡风险相关的因素:最新范围界定综述。
简介慢性阻塞性肺病(ECOPD)加重,尤其是导致住院治疗时,会增加死亡风险。我们的范围综述旨在确定短期和长期的最新死亡风险因素:我们在 2013 年 1 月至 2024 年 2 月期间进行了全面检索,以确定符合条件的研究,这些研究考虑了与住院 ECOPD 患者死亡相关的因素。我们考虑了一年以内的短期死亡率(包括院内死亡率,IHM)和一年以上的长期死亡率,没有时间限制。我们排除了有关重症监护领域的研究:我们考虑了 38 项研究,其中 32 项和 8 项分别报告了短期和长期死亡率数据。有两项研究同时考虑了这两个时间段。对一些因素进行了评估和讨论,其中有些是已知的,有些是新发现的。其中一些与慢性阻塞性肺病的特征和严重程度(年龄、体重指数、肺功能损害)有关,另一些则考虑了对 ECOPD 的反应。在最后一种情况下,我们重点关注生物标志物在预测患者死亡率,尤其是 IHM 方面日益重要的作用。我们发现的预后较差的相关因素可能有助于在临床实践中识别高危患者,进而确定个性化的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pulmonary function tests: an integrated approach to interpreting results in the search for treatable traits. Night-to-night variability in obstructive sleep apnoea: when might a multi-night measurement be helpful? Towards the integrated care of COPD, asthma and bronchiectasis: description and objectives of a treatable trait-based complex obstructive airway disease unit. Multifaceted pulmonary manifestations of amyloidosis: state-of-the-art update. The use of noninvasive positive pressure ventilation for severe asthma: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1